Fragment-based lead discovery: challenges and opportunities

被引：17
|
作者：
Sun, Chaohong [1 ]
Petros, Andrew M. [1 ]
Hajduk, Philip J. [1 ]
机构：
[1] Abbott Labs, Div Pharmaceut Discovery, Abbott Pk, IL 60064 USA
来源：
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN | 2011年 / 25卷 / 07期
关键词：
Fragment-based drug design; Biologics; Off-shoring; Outsourcing; DRUG DISCOVERY; DESIGN; INHIBITORS; BIOLOGICS; BIG;
D O I：
10.1007/s10822-011-9451-z
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Fragment-based lead discovery has undergone remarkable changes over the last 15 years. During this time, the pharmaceutical industry has changed dramatically as well, and continued evolution of the industry is assured. These changes present many challenges but also several opportunities for executing fragment-based drug design. This article will explore some of the more significant changes in the industry and how they may affect future discovery efforts related to fragment-based initiatives.
引用
收藏
页码：607 / 610
页数：4
相关论文
共 50 条
  • [11] Fragment-based lead discovery: leads by design
    Carr, RAE
    Congreve, M
    Murray, CW
    Rees, DC
    DRUG DISCOVERY TODAY, 2005, 10 (14) : 987 - 992
  • [12] Case studies in fragment-based lead discovery
    Congreve, MS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2763 - U2763
  • [13] Integration of chemoinformatics and fragment-based lead discovery
    Hoda, K
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U1036 - U1036
  • [14] Fragment-based lead discovery: a chemical update
    Erlanson, Daniel A.
    CURRENT OPINION IN BIOTECHNOLOGY, 2006, 17 (06) : 643 - 652
  • [15] Targeting Metalloproteins by Fragment-Based Lead Discovery
    Johnson, Sherida
    Barile, Elisa
    Farina, Biancamaria
    Purves, Angela
    Wei, Jun
    Chen, Li-Hsing
    Shiryaev, Sergey
    Zhang, Ziming
    Rodionova, Irina
    Agrawal, Arpita
    Cohen, Seth M.
    Osterman, Andrei
    Strongin, Alex
    Pellecchia, Maurizio
    CHEMICAL BIOLOGY & DRUG DESIGN, 2011, 78 (02) : 211 - 223
  • [16] Fragment-based lead discovery grows up
    Baker, Monya
    NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (01) : 5 - 10
  • [17] Recent progress in fragment-based lead discovery
    Schulz, Michele N.
    Hubbard, Roderick E.
    CURRENT OPINION IN PHARMACOLOGY, 2009, 9 (05) : 615 - 621
  • [18] Fragment-Based Lead Discovery Strategies in Antimicrobial Drug Discovery
    Konaklieva, Monika I.
    Plotkin, Balbina J.
    ANTIBIOTICS-BASEL, 2023, 12 (02):
  • [19] Fragment-based drug discovery: opportunities for organic synthesis
    St Denis, Jeffrey D.
    Hall, Richard J.
    Murray, Christopher W.
    Heightman, Tom D.
    Rees, David C.
    RSC MEDICINAL CHEMISTRY, 2021, 12 (03): : 321 - 329
  • [20] Mapping bioactivity space for fragment-based lead discovery
    Oprea, TI
    Olah, M
    Mracec, M
    Rad, R
    Ostopovici, L
    Bora, A
    Hadaruga, N
    Bologa, CG
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U157 - U157
12345